Chengcan Yang

518 total citations
14 papers, 368 citations indexed

About

Chengcan Yang is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Chengcan Yang has authored 14 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Chengcan Yang's work include Protein Degradation and Inhibitors (3 papers), Autophagy in Disease and Therapy (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Chengcan Yang is often cited by papers focused on Protein Degradation and Inhibitors (3 papers), Autophagy in Disease and Therapy (3 papers) and Hedgehog Signaling Pathway Studies (2 papers). Chengcan Yang collaborates with scholars based in China, United States and Poland. Chengcan Yang's co-authors include Liang Ouyang, Jifa Zhang, Guan Wang, Minru Liao, Yuxi Wang, Juncheng Chen, Pan Tang, Yang Li, Yong Yuan and Bo Liu and has published in prestigious journals such as ACS Applied Materials & Interfaces, Journal of Medicinal Chemistry and Drug Discovery Today.

In The Last Decade

Chengcan Yang

14 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengcan Yang China 11 263 74 48 39 38 14 368
Franziska Paech Switzerland 9 182 0.7× 55 0.7× 39 0.8× 25 0.6× 56 1.5× 10 345
Liwen Li China 11 230 0.9× 48 0.6× 57 1.2× 15 0.4× 43 1.1× 21 398
Yunjie Chen China 12 223 0.8× 35 0.5× 88 1.8× 16 0.4× 23 0.6× 19 397
Sathyen A. Prabhu United States 9 321 1.2× 94 1.3× 69 1.4× 27 0.7× 22 0.6× 12 454
Irene Marchesi Italy 14 315 1.2× 107 1.4× 85 1.8× 46 1.2× 17 0.4× 23 452
Serene Josiah United States 13 340 1.3× 80 1.1× 44 0.9× 36 0.9× 14 0.4× 25 485
Yichao Xu China 11 193 0.7× 46 0.6× 79 1.6× 18 0.5× 22 0.6× 34 339
Umesh Bhatia United States 9 311 1.2× 103 1.4× 33 0.7× 23 0.6× 20 0.5× 11 505

Countries citing papers authored by Chengcan Yang

Since Specialization
Citations

This map shows the geographic impact of Chengcan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengcan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengcan Yang more than expected).

Fields of papers citing papers by Chengcan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengcan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengcan Yang. The network helps show where Chengcan Yang may publish in the future.

Co-authorship network of co-authors of Chengcan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Chengcan Yang. A scholar is included among the top collaborators of Chengcan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengcan Yang. Chengcan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Li, Yang, Yun Liu, Dan Zhang, et al.. (2023). Discovery, Synthesis, and Evaluation of Novel Dual Inhibitors of a Vascular Endothelial Growth Factor Receptor and Poly(ADP-Ribose) Polymerase for BRCA Wild-Type Breast Cancer Therapy. Journal of Medicinal Chemistry. 66(17). 12069–12100. 14 indexed citations
2.
Liao, Minru, Qiang Xie, Yuqian Zhao, et al.. (2022). Main active components of Si-Miao-Yong-An decoction (SMYAD) attenuate autophagy and apoptosis via the PDE5A-AKT and TLR4-NOX4 pathways in isoproterenol (ISO)-induced heart failure models. Pharmacological Research. 176. 106077–106077. 63 indexed citations
3.
Zhang, Rui, et al.. (2022). Prognostic Predictors of Endodontic Microsurgery: Radiographic Assessment. International Dental Journal. 72(5). 628–633. 4 indexed citations
4.
Yang, Chengcan, et al.. (2022). Protocatechuic Acid-Based Supramolecular Hydrogel Targets SerpinB9 to Achieve Local Chemotherapy for OSCC. ACS Applied Materials & Interfaces. 14(32). 36379–36394. 15 indexed citations
5.
Chen, Juncheng, Pan Tang, Yuxi Wang, et al.. (2022). Targeting Bromodomain-Selective Inhibitors of BET Proteins in Drug Discovery and Development. Journal of Medicinal Chemistry. 65(7). 5184–5211. 36 indexed citations
6.
7.
Zhang, Le, Lei Zhang, Ming Xiao, et al.. (2021). MCDB: A comprehensive curated mitotic catastrophe database for retrieval, protein sequence alignment, and target prediction. Acta Pharmaceutica Sinica B. 11(10). 3092–3104. 34 indexed citations
8.
Xu, Tian, Jifa Zhang, Chengcan Yang, et al.. (2021). Identification and optimization of 3-bromo-N’-(4-hydroxybenzylidene)-4-methylbenzohydrazide derivatives as mTOR inhibitors that induce autophagic cell death and apoptosis in triple-negative breast cancer. European Journal of Medicinal Chemistry. 219. 113424–113424. 13 indexed citations
9.
Li, Yang, Chengcan Yang, Pan Tang, et al.. (2021). Targeting Autophagy-Related Epigenetic Regulators for Cancer Drug Discovery. Journal of Medicinal Chemistry. 64(16). 11798–11815. 13 indexed citations
10.
11.
Zhang, Jifa, Pan Tang, Ling Zou, et al.. (2021). Discovery of Novel Dual-Target Inhibitor of Bromodomain-Containing Protein 4/Casein Kinase 2 Inducing Apoptosis and Autophagy-Associated Cell Death for Triple-Negative Breast Cancer Therapy. Journal of Medicinal Chemistry. 64(24). 18025–18053. 32 indexed citations
12.
Gao, Qian, et al.. (2020). Novel PTCH1 mutation in Gorlin–Goltz syndrome potentially altered interactions with lipid bilayer. Oral Diseases. 27(3). 475–483. 4 indexed citations
13.
Yang, Chengcan, Jifa Zhang, Minru Liao, et al.. (2020). Folate-mediated one-carbon metabolism: a targeting strategy in cancer therapy. Drug Discovery Today. 26(3). 817–825. 72 indexed citations
14.
Gao, Qian, Chengcan Yang, Liuyan Meng, et al.. (2020). Activated KCNQ1 channel promotes fibrogenic response in hereditary gingival fibromatosis via clustering and activation of Ras. Journal of Periodontal Research. 56(3). 471–481. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Franziska Paech Breakdown of academic impact, for papers by Liwen Li Breakdown of academic impact, for papers by Yunjie Chen Breakdown of academic impact, for papers by Sathyen A. Prabhu Breakdown of academic impact, for papers by Irene Marchesi Breakdown of academic impact, for papers by Serene Josiah Breakdown of academic impact, for papers by Yichao Xu Breakdown of academic impact, for papers by Umesh Bhatia
Rankless by CCL
2026